Proton Therapy Market Report Global Forecast by Indication (Head & Neck Cancer, Sarcoma, Pediatric Cancer, Gastro-intestinal Cancer, Prostate Cancer, Lung Cancer), Set-up Type (Single Room, Multi – Room), Country and Company Analysis 2025-2033
Buy NowProton Therapy Market Size
Proton Therapy Market will reach US$ 7.19 billion by 2033, up from US$ 2.44 billion in 2024, with a CAGR of 12.76% between 2025 and 2033. Technological advancements, improved awareness of the benefits of proton therapy over traditional radiation therapies, rising cancer incidence, government funding, and the growing need for targeted treatments are some of the causes propelling its expansion.
Proton Therapy Industry Outlooks
Proton therapy is an ingenious form of radiation therapy that treats cancer by using positively charged particles called protons rather than X-rays. Proton treatment uses high-velocity acceleration to precisely target the location of cancer cells. Proton therapy's primary benefit over other types of radiation therapy is its ability to target the tumor with little exposure of healthy surrounding tissues, which reduces the likelihood of adverse consequences.
In parts of the body including the scalp, spine, eyes, and brain where delicate tissues are at risk, proton treatment is very helpful. Lung cancer, prostate cancer, pediatric malignancies and head and neck cancer are some forms of brain tumors are among the cancers that are commonly treated with it. Because of its accuracy, it is a recommended option for treating patients who need high radiation dosages but whose surrounding healthy tissues and organs must also be preserved for improved results and quality of life.
Proton therapy's growth drivers include the increasing prevalence of cancer, improvements in treatment precision brought about by proton technology advancements, the growing need for targeted therapies with fewer side effects, and growing patient and healthcare provider awareness of the advantages of proton therapy over traditional radiation. Market expansion is also being aided by institutional and governmental backing.
| Report Features | Details |
|
Base Year |
2024 |
|
Forecast Years |
2025 - 2033 |
|
Historical Years |
2020 - 2033 |
|
Market Size in 2024 |
US$ 2.44 Billion |
|
Market Forecast in 2033 |
US$ 7.19 Billion |
|
Market Growth Rate (2025-2035) |
12.76% |
Growth Driver in the Proton Therapy Market
Rising Cancer Incidence Worldwide
One of the main factors propelling proton therapy's expansion is the increased prevalence of cancer. Effective treatment options are becoming more and more necessary as cancer rates continue to rise worldwide as a result of variables like an aging population, lifestyle choices, and environmental impacts. According to WHO estimates, cancer kills 10 million people annually, making it the leading cause of death. Nearly 20 million new instances of cancer were reported in 2022, and an estimated 9.7 million people died from the disease. Additionally, the Globocan predicted that by 2040, over 30 million individuals worldwide will be living with cancer. Therefore, it is anticipated that the high global cancer burden will fuel market expansion in the next years.
A focused approach is provided by proton therapy, which minimizes harm to nearby healthy tissue while delivering strong radiation doses directly to malignancies. Because of its accuracy, it is especially useful for treating a variety of malignancies, including those in children, where it is essential to preserve healthy tissue. Proton treatment is anticipated to become more popular as patients and medical professionals become more aware of it, which will increase funding for proton therapy facilities. Continuous research showing its efficacy in enhancing patient outcomes further supports this trend, increasing demand in the oncology market.
Increasing Healthcare Awareness and Investments
Higher levels of awareness about the benefits of proton therapy are pushing healthcare providers to make investments in this technology. Governments and private organizations realize its potential, allowing for enhanced funding for proton therapy centers. In fact, many developed countries are doubling their cancer care infrastructure with proton therapy facilities while emerging markets are in pursuit. The growth is further driven by medical tourism, where patients increasingly travel for advanced treatments offered in other countries. The surge in public health campaigns educating patients on non-invasive cancer treatment is also accelerating general adoption of proton therapy globally. In February 2023, IBA Radiopharma Solutions partnered with Moffitt Cancer Center to introduce proton therapy treatment to Speros, FL, located in the heart of Pasco County's Global Innovation Center.
United States Proton Therapy Market
The United States is a major player in the global proton therapy industry. The economy is further agitated by the improvements in the American healthcare system and the pressing need for novel cancer treatments. There are many proton therapy facilities in the US that offer cutting-edge treatments for tumors of the brain, lungs, and prostate. The market is expanding as a result of rising cancer cases, advances in technology, and significant investments in the public and private sectors. The American Cancer Society announced in January 2024 that more than 18 million Americans had a history of cancer in 2022. In 2024, it is anticipated that more than 2 million new instances of cancer will be diagnosed in the US.
The use of proton treatment is being further promoted by a recent rise in understanding of its high precision and low side effects. The market for proton treatment in the United States is anticipated to develop moderately over the next years as access to this technology continues to improve. The market was boosted in June 2024 when McLaren Health Care acquired Leo Cancer Care and made an investment in a proton therapy developer.
France Proton Therapy Market
The market for proton therapy is expanding quickly in France as a result of the nation's robust healthcare system and emphasis on cutting-edge cancer treatment. France is at the forefront of European cancer treatment advancements because to its numerous significant proton therapy centers spread throughout cities like Paris and Nice. Proton treatment usage is encouraged by governments' strong support for healthcare spending and precision medicine research. The rising number of cancer cases and increased knowledge of the advantages of treatment, such as its good results and low side effects, will support the growth of the French sector in the years to come. The National Center for Radiation Research and German researchers at OncoRay Dresden University Medical Center worked together on MRI-based proton treatment in January 2024.
Proton Therapy Company Analysis
Some key players in the global proton therapy industry are IBA, Varian Medical System, Hitachi Ltd, Mevion Medical Systems, and Mitsubishi Electric Corporation.
Proton Therapy Company News
January 2024: Through its Chinese subsidiary, an Israeli P-cure company began constructing a proton therapy center to give Chinese cancer patients access to affordable treatment.
October 2023: An important milestone in Southeast Asia was reached when Hitachi Ltd. delivered its first proton treatment system to the National Cancer Center in Singapore.
April 2023: Researchers from the University of Pittsburgh and UTSA worked together to investigate the application of AI for adaptive radiation, which may eventually take the role of existing techniques for tumor treatment and picture evaluation.
Indication- Market breakup in 6 viewpoints:
- Head & Neck Cancer
- Sarcoma
- Pediatric Cancer
- Gastro-intestinal Cancer
- Prostate Cancer
- Lung Cancer
Set-up Type- Market breakup in 2 viewpoints
- Single Room
- Multi – Room
Countries- Market breakup in 19 Countries
North America
- United States
- Canada
Europe
- France
- Germany
- Italy
- United Kingdom
- Austria
- Belgium
- Czech Republic
- Denmark
- Spain
- Switzerland
Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
- Singapore
Middle East
- Saudi Arabia
All companies have been covered from 4 viewpoints
- Business overview
- Key Persons
- Recent Development & Strategies
- Sales Analysis
Key Players Analysis
- IBA
- Varian Medical System
- Hitachi Ltd.
- Mevion Medical Systems
- Mitsubishi Electric Corporation
Report Details:
| Report Features | Details |
| Base Year |
2024 |
| Historical Period |
2020 - 2033 |
| Forecast Period |
2025 - 2033 |
| Market |
US$ Billion |
| Segment Covered | Indication, Set-up Type and Countries |
| Countries Covered |
North America
Europe
Asia Pacific
Middle East & Africa
|
| Companies Covered |
|
| Customization Scope |
20% Free Customization |
| Post-Sale Analyst Support |
1 Year (52 Weeks) |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request) |
Customization Services available
- Analysis of Market Size and Its Segments
- More Company Profiles (Upto 10 without any additional cost):
- Additional Countries (Other than mentioned Countries):
- Region/Country Specific Reports:
- Market Entry Strategy:
- Region-Specific Market Dynamics:
- Regional Market Share Analysis:
- Trade Analysis:
- Production Insights:
- Others Customized Requests:
For more information contact our analysts.
Need More Assistance?
- Talk to our analysts to get more precious information on the current market trends.
- Include more countries and segments and customize the report based on the final requirement.
- Get a competitive advantage in your industry by knowing the report findings and making a positive impact on your revenues and operations.
- Our analysts are always ready to provide more help and pertinent information if you need any additional assistance.
1. Introduction
2. Research & Methodology
3. Executive Summary
4. Market Dynamics
4.1 Growth Drivers
4.2 Challenge
5. Global Proton Therapy Market
5.1 Historical Trend
5.2 Forecast Trend
6. Market Share Analysis
6.1 By Indication
6.2 By Set-up Type
6.3 By Countries
7. Indication
7.1 Head & Neck Cancer
7.2 Sarcoma
7.3 Pediatric Cancer
7.4 Gastro-intestinal Cancer
7.5 Prostate Cancer
7.6 Lung Cancer
8. Set-up Type
8.1 Single Room
8.2 Multi – Room
9. Countries
9.1 North America
9.1.1 United States
9.1.2 Canada
9.2 Europe
9.2.1 France
9.2.2 Germany
9.2.3 Italy
9.2.4 United Kingdom
9.2.5 Austria
9.2.6 Belgium
9.2.7 Czech Republic
9.2.8 Denmark
9.2.9 Spain
9.2.10 Switzerland
9.3 Asia Pacific
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 South Korea
9.3.5 Thailand
9.3.6 Singapore
9.4 Middle East
9.4.1 Saudi Arabia
10. Porter’s Five Forces Analysis
10.1 Bargaining Power of Buyers
10.2 Bargaining Power of Suppliers
10.3 Degree of Rivalry
10.4 Threat of New Entrants
10.5 Threat of Substitutes
11. SWOT Analysis
11.1.1 Strength
11.1.2 Weakness
11.1.3 Opportunity
11.1.4 Threat
12. Reimbursement Policy
12.1 Reimbursement Policies for Patients
12.2 Reimbursement for Institutions, Stakeholders and Manufacturers
13. Components of a Standard Proton Therapy Center
13.1 Proton Accelerator
13.1.1 Synchrotrons (example: LLUMC at Loma Linda)
13.1.2 Cyclotrons (example: MGH Boston)
13.1.3 Synchrocyclotrons (examples: Orsay, Uppsala)
13.1.4 Linacs (Rome)
13.1.5 H-minus Synchrotrons
13.1.6 Separated Sector Cyclotrons
13.1.7 Super-conducting Cyclotrons
13.1.8 Fast Cycling Synchrotron
13.2 Beam Transport System
13.3 Beam Delivery System
13.3.1 The Passive Scattering Technique
13.3.2 Beam Scanning
13.4 Nozzle
13.4.1 Single Scattering
13.4.2 Double Scattering
13.4.3 Uniform Scanning Nozzle
13.4.4 Pencil Scanning Nozzle
13.5 Treatment Planning System
13.6 Image Viewers
13.7 Patient Positioning System (PPS)
13.8 Human Resource
14. Key Players Analysis
14.1 IBA
14.1.1 Business overview
14.1.2 Key Persons
14.1.3 Recent Development & Strategies
14.1.4 Sales Analysis
14.2 Varian Medical System
14.2.1 Business overview
14.2.2 Key Persons
14.2.3 Recent Development & Strategies
14.2.4 Sales Analysis
14.3 Hitachi Ltd.
14.3.1 Business overview
14.3.2 Key Persons
14.3.3 Recent Development & Strategies
14.3.4 Sales Analysis
14.4 Mevion Medical Systems
14.4.1 Business overview
14.4.2 Key Persons
14.4.3 Recent Development & Strategies
14.4.4 Sales Analysis
14.5 Mitsubishi Electric Corporation
14.5.1 Business overview
14.5.2 Key Persons
14.5.3 Recent Development & Strategies
14.5.4 Sales Analysis
Reach out to us
Call us on
USA: +1-678-302-0700
INDIA: +91-120-421-9822
Drop us an email at
info@renub.com